Randomized phase II trial (RENO): Efficacy results of oral vinorelbine or etoposide combined with cisplatin in chemo-radiotherapy treatment of locally advanced NSCLC (LA-NSCLC)-SLCG 10/02.

被引：2
|
作者：
Provencio, Mariano
de las Penas, Ramon
Insa, Amelia
Martinez-Banaclocha, Natividad
Fabregat, Raquel Marse
Sanchis, Pilar Mut
Moran, Teresa
Sala, Angeles
Massuti, Bartomeu
Ortega, Ana Laura
Jurado, Jose Miguel
Gomez-Codina, Jose
Diz, Pilar
Artal-Cortes, Angel
Calderon, Vanesa Gutierrez
Vazquez, Maria Francisca
Vinolas, Nuria
Quintana, Miguel Angel Munoz
Garcia-Gomez, Ramon
Isla, Dolores
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.8538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8538
引用
收藏
页数：3
相关论文
共 50 条
  • [41] PRELIMINARY RESULTS OF INDUCTION CISPLATIN/DOCETAXEL FOLLOWED BY SHORT COURSE THORACIC RADIOTHERAPY AND CISPLATIN/DOCETAXEL OF CONSOLIDATION IN LOCALLY. ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A PROSPECTIVE PHASE II TRIAL
    Genestreti, Giovenzio
    Piciucchi, Sara
    Romeo, Antonino
    Parisi, Elisabetta
    Monti, Manuela
    Giovannini, Noemi
    Poletti, Venerino
    Matteucci, Federica
    Polico, Rolando
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1268 - S1269
  • [42] MULTICENTER PHASE II STUDY OF S-1 (S) PLUS CISPLATIN (P) WITH CONCURRENT THORACIC RADIOTHERAPY (TRT) FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC): WEST JAPAN ONCOLOGY GROUP (WJOG) 3706 TRIAL
    Daga, H.
    Yamanaka, T.
    Sasaki, T.
    Katakami, N.
    Sawa, T.
    Kudoh, S.
    Saka, H.
    Ichinose, Y.
    Nishimura, Y.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 135 - 135
  • [43] Cisplatin (CDDP) and oral vinorelbine (NVBO) concomitantly with radiotherapy (RT) after induction chemotherapy (CT) in locally advanced (LA) non-small cell lung cancer (NSCLC) treatment: Clinical experience in five institutions in Spain
    Remon, J.
    Diaz Padilla, I.
    Andrade, J.
    Gasco, A.
    Jurado, J. M.
    Perez, F. J.
    Lianes, M. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Concomitant chemo-radiotherapy with oral vinorelbine and cisplatin after induction chemotherapy with cisplatin-docetaxel in patients with locally advanced non-small cell lung cancer: a multicenter phase II trial. GFPC study 05-03 (French cooperative group of thoracic oncology)
    Robinet, Gilles
    Fournel, Pierre
    Berard, Henri
    Falchero, Lionel
    Kahlout, Sana
    Monnet, Isabelle
    Chouabe, Stephane
    Geriniere, Laurence
    Bota, Suzanna
    Locher, Chrystele
    Thomas, Pascal
    Chajara, Abdesslam
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S861 - S861
  • [45] Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional chemo-radiotherapy for locally advanced (LA) head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial
    Tao, Y.
    Auperin, A.
    Blanchard, P.
    Alfonsi, M.
    Sun, X-S.
    Rives, M.
    Pointreau, Y.
    Castelli, J.
    Graff, P.
    Kam, S. Wong Hee
    Thariat, J.
    Veresezan, O.
    Cornely, A.
    Casiraghi, O.
    Lapeyre, M.
    Bourhis, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [46] ORAL VINORELBINE (NVBO) AND CISPLATIN (P) OR PEMETREXED (PEM) AND P AS FIRST-LINE CHEMOTHERAPY FOR NON SQUAMOUS (NS) METASTATIC OR LOCALLY ADVANCED NON SMALL CELL LUNG CANCER (M OR LA NSCLC): FINAL RESULTS OF A PROSPECTIVE RANDOMISED PHASE II TRIAL (NAVOTRIAL 1)
    Tan, Eng-Huat
    Krzakowski, Maciej
    Kollmeier, Jens
    Gervais, Radj
    Dansin, Eric
    Serke, Monika
    Favaretto, Adolfo
    Havel, Libor
    Cobo, Manuel
    Szczesna, Aleksandra
    Ciuffreda, Libero
    Jassem, Jacek
    Nicolini, Mario
    Ramlau, Rodryg
    Amoroso, Domenico
    Melotti, Barbara
    Almodovar, Maria Teresa
    Vaissiere, Nathalie
    Riggi, Marcello
    Bennouna, Jaafar
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S289 - S289
  • [47] OPEN-LABEL, RANDOMIZED MULTICENTRE, PHASE II TRIAL OF ORAL VINORELBINE (NVBO) OR INTRAVENOUS VINORELBINE (NVBIV) WITH CISPLATIN (CDDP) IN PATIENTS (PTS) WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): A CHINESE EXPERIENCE (CA225 STUDY)
    Li Zhang
    Chang Jianhua
    Cheng Huang
    Jie Wang
    Shu Yongqian
    Zhang, Yiping
    Burillon, Jean-Philippe
    Vaissiere, Nathalie
    Riggi, Marcello
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1161 - S1162
  • [48] Multicenter randomized phase II trial of combined radiotherapy and cisplatin with or without erlotinib in patients with locally advanced squamous cell carcinoma of the head and neck (SCCAHN): Preliminary toxicity results.
    Hayes, D. N.
    Raez, L. E.
    Sharma, A. K.
    Papagikos, M. A.
    Yunus, F.
    Parvathaneni, U.
    Eaton, K. D.
    Futran, N.
    Wallace, S. G.
    Martins, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] PHASE II TRIAL OF LOW-DOSE METRONOMIC ORAL VINORELBINE COMBINED WITH BEVACIZUMAB IN PATIENTS WITH PRETREATED, ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC). PRELIMINARY RESULTS
    Kontopodis, E.
    Saridaki, Z.
    Kentepozidis, N.
    Giassas, S.
    Polyzos, A.
    Bobolaki, I.
    Christophyllakis, Ch
    Patramani, S.
    Rovithi, M.
    Georgoulias, V.
    Agelaki, S.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1244 - S1245
  • [50] Prospective randomized phase II trial of oral vinorelbine (NVBo) and cisplatin (P) or pemetrexed (Pem) and P in first-line metastatic or locally advanced non-small cell lung cancer (M or LA NSCLC) patients (pts) with nonsquamous (non SCC) histologic type: NAVoTRIAL01-Preliminary results
    Bennouna, Jaafar
    Zatloukal, Petr
    Krzakowski, Maciej Jerzy
    Kollmeier, Jens
    Riviere, Alain
    Dansin, Eric
    Serke, Monika
    Favaretto, Adolfo G.
    Havel, Libor
    Malasse, Stephanie
    Biville-Hedouin, Fabienne
    Tan, Eng Huat
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345